Oral vancomycin may have significant absorption in patients with Clostridium difficile colitis

Author： Chihara Shingo   Shimizu Riha   Furukata Satoshi   Hoshino Koichi  

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.43, Iss.2, 2011-02, pp. : 149-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Systemic absorption of oral vancomycin in patients with Clostridium difficile infection

By Rao Sriharsha   Kupfer Yizhak   Pagala Murali   Chapnick Edward   Tessler Sidney  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 5, 2011-05 ,pp. : 386-388

Informa Healthcare

Access to resources Recommend Favorite

Risk Factors for Systemic Vancomycin Exposure Following Administration of Oral Vancomycin for the Treatment of Clostridium difficile Infection

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 2, 2015-02 ,pp. : 119-126

John Wiley & Sons Inc

Access to resources Recommend Favorite

Postantibiotic Colonization with Clostridium difficile in Nursing Home Patients

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 38, Iss. 4, 1990-04 ,pp. : 415-420

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clostridium difficile infection in hospitalized octogenarian patients

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 18, Iss. 2, 2018-02 ,pp. : 315-320

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 9, 2015-05 ,pp. : 835-843

John Wiley & Sons Inc

Access to resources Recommend Favorite